Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG PET: Histopathologic Comparison

Radiology

Volumn 230, Issue 2, 2004, Pages 417-422

  Agress Jr , Harry ^a   Cooper, Benjamin Z ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Comparative studies; Neoplasms; PET; Positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; COMPARATIVE ANATOMY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ENDOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRECANCER; PRIORITY JOURNAL; WHOLE BODY RADIATION;

AGED; AGED, 80 AND OVER; BIOPSY; BLOOD GLUCOSE; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1642458199     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2302021685     Document Type: Article

References (26)

1. Bar-Shalom R, Valdivia AY, Blaufox D. PET imaging in oncology. Semin Nucl Med 2000; 30:150-185.
2. Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999; 40:1706-1715.
3. Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 2003; 23:315-340.
4. Coleman RC. PET in lung cancer. J Nucl Med 1999; 40:814-820.
5. Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of 18F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002; 43:492-499.
6. Schoder H, Meta J, Yap C, et al. Effect of whole-body 18F-FDG PET on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42:1139-1143.
7. Yap CS, Seltzer MA, Schiepers C, et al. Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. J Nucl Med 2001; 42:1334-1337.
8. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19:3745-3749.
9. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000; 41:816-822.
10. Eubank WB, Mankoff DA, Vesselle HJ, et al. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. RadioGraphics 2002; 22:5-17.
11. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 53:750-770.
12. Vesselle HJ, Miraldi FD. FDG-PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. RadioGraphics 1998; 18:805-823.
13. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61-77.
14. Lum DP, Wandell S, Ko J, Coel MN. Reduction of myocardial 2-Deoxy-2-[18F] fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. Mol Imag Biol 2002; 4:232-237.
15. Dakins DR. Plan for growth when establishing a PET center. Diagn Imaging, December 2002 (suppl); 11-16.
16. Tatlidil R, Jadavar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002; 224:783-787.
17. Yasuda S, Fujii H, Nakahara T, et al. 18F-FDG PET detection of colonic adenomas. J Nucl Med 2001; 42:989-992.
18. Zhuang H, Hickeson M, Chacko TK, et al. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 2002; 27:628-632.
19. Yasuda S, Takahashi W, Takagi S, Ide M, Shohtsu A. Primary colorectal cancers detected with PET. Jpn J Clin Oncol 1998; 28:638-640.
20. Ramos CD, Chisin R, Yeung HWD, Larson SM, Macapinlac HA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001; 26:193-197.
21. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002; 87:1517-1520.
22. Lentz SS. Endometrial carcinoma diagnosed by positron emission tomography: a case report. Gyn Oncol 2002; 86:223-224.
23. Bakheet SMB, Powe J, Ezzat A, Bakri Y. Incidental second primary in the breast detected by F-18 FDG positron emission tomography scan. Clin Nucl Med 1998; 23:616.
24. Yasuda S, Kubota M, Tajima T, et al. A small breast cancer detected by PET. Jpn J Clin Oncol 1999; 29:387-389.
25. Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 2000; 83:1607-1611.
26. Ide M, Nakai K, Takahashi W, et al. Cancer screening with 18f-FDG PET (abstr). J Nucl Med 2002; 43(P):309.